Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Total 13F shares
-
12,323,877
-
Share change
-
-768,764
-
Total reported value
-
$86,267,610
-
Price per share
-
$7.00
-
Number of holders
-
51
-
Value change
-
-$5,590,592
-
Number of buys
-
23
-
Number of sells
-
21
Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2017
As of 31 Dec 2017,
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,323,877 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Cormorant Asset Management, LLC, BlackRock Inc., Hillhouse Capital Management, Ltd., Rock Springs Capital Management LP, Vanguard Group Inc, PERCEPTIVE ADVISORS LLC, FMR LLC, SPHERA FUNDS MANAGEMENT LTD., and FIRST MANHATTAN CO.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.